ArticleCancers2024

Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling Pathways.

Narmen Esmael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.